EE568 Economic Evaluation of the Co-Formulated Antiretroviral Efavirenz 400mg/Lamivudine/Tenofovir Disoproxil Fumarate for the Treatment of HIV-1 Infection in Adult Patients From the Perspective of the Mexican Public Health System
Abstract
Authors
MM Palecek-Rodríguez EJ Palomo Paz Y Escobar H Soto Molina G Mendoza Medrano M Rozycka